3 free views remaining today
retinitis pigmentosa 6
ICD-10 Codes
Related ICD-10:
Description
Retinitis Pigmentosa (RP) Description
Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous group of inherited retinal disorders characterized by diffuse [6].
This condition affects the retina, leading to progressive loss of night and peripheral vision. In some cases, it can cause complete blindness [7].
The symptoms of RP include:
- Trouble with night vision
- Loss of peripheral vision
- Gradual deterioration of central vision
RP is a group of inherited eye diseases that affect the retina's ability to respond to light, causing a slow loss of vision [1]. It involves the eye's retina and can lead to progressive vision loss [5].
References:
- [6] CC Chow · Cited by 1 — Disease.
- [7] is an inherited retinal disease causing progressive loss of night and peripheral vision.
- [1] Nov 11, 2024 — Retinitis pigmentosa is a group of genetic disorders that affect the retina's ability to respond to light, causing a slow loss of vision.
- [5] Oct 1, 2010 — Retinitis pigmentosa is a group of related eye disorders that cause progressive vision loss. These disorders affect the retina.
Additional Characteristics
- Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous group of inherited retinal disorders characterized by diffuse
- This condition affects the retina, leading to progressive loss of night and peripheral vision.
- The symptoms of RP include:
- * Trouble with night vision
- * Loss of peripheral vision
- * Gradual deterioration of central vision
- RP is a group of inherited eye diseases that affect the retina's ability to respond to light, causing a slow loss of vision
Signs and Symptoms
Retinitis Pigmentosa (RP) Signs and Symptoms
Retinitis pigmentosa (RP) is a genetic disorder that affects the retina, leading to progressive vision loss. The signs and symptoms of RP can vary from person to person, but here are some common ones:
- Loss of night vision: Night blindness is when you cannot see anything in the dark. This is often one of the first signs of RP.
- Gradual loss of peripheral (side) vision: As RP progresses, people may experience a gradual loss of side vision, which can lead to tunnel vision.
According to [6], "Loss of night vision. Night blindness is when you cannot see anything in the dark." This suggests that night blindness is a common symptom of RP.
Additionally, [7] states that "Signs and symptoms of RP may include loss of night vision (night blindness), gradual loss of side (peripheral) vision (tunnel vision) where people have difficulty seeing objects or events on the periphery."
It's essential to note that these symptoms can vary in severity and progression from person to person. If you're experiencing any of these symptoms, it's crucial to consult with an eye care professional for proper diagnosis and treatment.
References: [6] Nov 11, 2024 — Retinitis Pigmentosa Symptoms [7] Nov 6, 2024 — Signs and symptoms of RP
Additional Symptoms
- * Loss of night vision
- * Gradual loss of peripheral (side) vision
Diagnostic Tests
Diagnostic Tests for Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a genetic disorder that affects the retina, leading to progressive vision loss. Diagnostic tests play a crucial role in confirming the diagnosis and monitoring the progression of RP.
- Electroretinogram (ERG): Considered the gold-standard modality for diagnosing RP, ERG measures the electrical activity of the retina in response to light stimulation [6]. It can detect abnormalities in rod and cone function across the retina.
- Dilated Eye Exam: A comprehensive eye examination that includes a dilated pupil to examine the retina and optic nerve is essential for diagnosing RP. This test can reveal characteristic changes such as pigment deposits, loss of photoreceptors, and peripheral visual field loss [4].
- Visual Field Testing: This test assesses peripheral vision by measuring how well you can see objects in your side vision. It's an important diagnostic tool for RP, as patients often experience progressive peripheral visual field loss [7].
- Genetic Test: A genetic test can confirm the presence of a specific gene mutation associated with RP.
- Electro-oculogram (EOG): While not helpful in diagnosing RP, EOG measures the electrical activity of the retina and can be used to monitor disease progression.
These diagnostic tests help healthcare professionals confirm the diagnosis of retinitis pigmentosa and develop an effective treatment plan.
Additional Diagnostic Tests
- Electroretinogram (ERG)
- Genetic Test
- Dilated Eye Exam
- Visual Field Testing
Treatment
Current Drug Treatments for Retinitis Pigmentosa
While there are no definitive cures for retinitis pigmentosa (RP), various drug treatments aim to slow down the progression of the disease or improve visual function. Some of these treatments include:
- Voretigene Neparvovec-Rzyl (Luxturna): This is a gene therapy product approved by the FDA to treat a specific type of RP caused by mutations in the RPE65 gene. It works by replacing the faulty gene with a healthy one, allowing cells to produce a functional version of the protein [1].
- Oral Acetazolamide: Studies have shown that this carbonic anhydrase inhibitor can improve visual function in some patients with RP [5]. However, more research is needed to confirm its effectiveness.
- Retinoids and Vitamin A Supplements: These conventional therapies can slow down the progression of RP but do not offer a cure. They work by protecting the retina from further damage [9].
It's essential to note that these treatments may have varying degrees of success depending on the individual case, and more research is needed to fully understand their potential benefits and limitations.
References:
[1] Context 6: The FDA has approved voretigene neparvovec-ryzl (Luxturna), a gene therapy product to treat a specific type of retinitis pigmentosa. People with mutations in the RPE65 gene may benefit from this treatment. [5] Context 5: Of the many therapies tried, oral acetazolamide has shown the most encouraging results with some improvement in visual function. Studies by [9] have also explored the use of retinoids and vitamin A supplements to slow down RP progression. [9] Context 9: The current conventional therapies, which only slow the progression of the disease, include retinoids, vitamin A supplements, protection from further damage, and other treatments.
Recommended Medications
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Retinitis Pigmentosa
Retinitis pigmentosa (RP) is a group of inherited disorders characterized by progressive peripheral vision loss and night vision difficulties, which can lead to central vision loss. When diagnosing RP, it's essential to consider other genetic disorders that cause retinal degeneration.
Other Differential Diagnoses:
- Gyrate atrophy
- Choroideremia
- Leber's congenital amaurosis (LCA)
- Usher syndrome
- Waardenburg syndrome
- Alport syndrome
- Refsum disease
- Kearns-Sayre syndrome
These conditions can present with similar symptoms to RP, making differential diagnosis crucial for accurate diagnosis and treatment. A comprehensive evaluation by an ophthalmologist or geneticist is necessary to rule out these conditions.
References:
- Carr & Heckenlively's chapter in Clinical Ophthalmology
- Roberta Pagon's review article "Retinitis pigmentosa"
- Nakahara et al., 2021 (search result 3) - This study highlights the importance of differential diagnosis in RP, citing several conditions that can mimic the disease.
Note: The information provided is based on search results 2 and 6.
Additional Differential Diagnoses
- Leber's congenital amaurosis (LCA)
- Usher syndrome
- Alport syndrome
- Waardenburg syndrome
- Refsum disease
- Kearns-Sayre syndrome
- gyrate atrophy
- choroideremia
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4767
- owl#annotatedSource
- t365915
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#hasDbXref
- MIM:312612
- oboInOwl#id
- DOID:0110413
- core#notation
- DOID:0110413
- IAO_0000115
- A retinitis pigmentosa that has_material_basis_in variation in the chromosome region Xp21.3-p21.2.
- rdf-schema#label
- retinitis pigmentosa 6
- oboInOwl#hasExactSynonym
- RP6
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_10584
- relatedICD
- http://example.org/icd10/H35.5
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.